Integrated Cardiopulmonary Pharmacology — 5th
Edition
Original Exam Mastery & Clinical Pharmacology Study Guide • 2026
Scope: 100 independently authored practice questions covering the publicly visible 15-chapter structure of the Fifth Edition, with
emphasis on mechanisms, medication safety, cardiopulmonary application, calculations, and emergency reasoning.
Originality: This resource does not reproduce, reconstruct, or provide the paid Stuvia test bank or publisher test-bank questions.
All questions and explanations here were newly authored for study use.
Source alignment: The referenced Stuvia listing is a paid 1,349-page test-bank resource; its public preview shows Chapter 1 and the related public
Fifth Edition listing identifies chapters on general pharmacology, dosage calculations, autonomic pharmacology, aerosols, bronchodilators,
mucokinetics/surfactants, antiasthmatics, antimicrobials, cardiac agents, blood-pressure/antithrombotic agents,
neuromuscular/sedative/anesthetic/analgesic agents, therapeutic gases, obstructive pulmonary disease, respiratory infections, and emergency
cardiovascular life support. ■cite■turn0view0■turn0search0■
Current evidence note: Drug-development material is aligned with current FDA descriptions of preclinical research, clinical phases, regulatory review,
and post-market monitoring. ■cite■turn1search0■turn1search4■
Integrated Cardiopulmonary Pharmacology — Original Exam Mastery 2026 Page 1
, Study Strategy
• Use active recall: answer before reading the explanation.
• Build every medication around mechanism → indication → onset/duration → adverse effects → monitoring → teaching.
• For respiratory deterioration, assess airway, work of breathing, oxygenation, ventilation, and response.
• For cardiovascular deterioration, prioritize perfusion, rhythm, ischemia, blood pressure, and medication toxicity.
• For calculations, keep units visible and verify unusual results before administration.
Chapter Map
1. General Pharmacology — 6–10 questions
2. Dosage Calculations — 6–10 questions
3. Autonomic Pharmacology — 6–10 questions
4. Aerosol Therapy — 6–10 questions
5. Bronchodilators — 6–10 questions
6. Mucokinetics & Surfactants — 6–10 questions
7. Anti-inflammatory & Antiasthmatic Agents — 6–10 questions
8. Antimicrobial Agents — 6–10 questions
9. Cardiac Agents — 6–10 questions
10. Blood Pressure & Antithrombotic Agents — 6–10 questions
11. Neuromuscular, Sedative, Anesthetic & Analgesic Agents — 6–10 questions
12. Therapeutic Medical Gases — 6–10 questions
13. Obstructive Pulmonary Disease — 6–10 questions
14. Respiratory Infectious Diseases — 6–10 questions
15. Emergency Cardiovascular Life Support — 6–10 questions
Integrated Cardiopulmonary Pharmacology — Original Exam Mastery 2026 Page 2
, Chapter 1: General Pharmacology
1. Which statement is most accurate? Pharmacokinetics describes what the body does to a drug.
A. It is unrelated to medication safety or clinical monitoring.
B. It should be ignored unless symptoms persist for several months.
C. It has the opposite physiologic effect in every patient.
D. pharmacokinetics
Answer: D
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
2. Which finding or action best matches this concept? Pharmacokinetics describes what the body does to a drug.
A. pharmacokinetics
B. It should be ignored unless symptoms persist for several months.
C. It is unrelated to medication safety or clinical monitoring.
D. It has the opposite physiologic effect in every patient.
Answer: A
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
3. Which exam answer best demonstrates understanding of this principle? Pharmacokinetics describes what the body does to
a drug.
A. pharmacokinetics
B. It has the opposite physiologic effect in every patient.
C. It is unrelated to medication safety or clinical monitoring.
D. It should be ignored unless symptoms persist for several months.
Answer: A
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
4. Which option should a clinician recognize as correct? Pharmacokinetics describes what the body does to a drug.
A. It should be ignored unless symptoms persist for several months.
B. It is unrelated to medication safety or clinical monitoring.
C. pharmacokinetics
D. It has the opposite physiologic effect in every patient.
Answer: C
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
5. Which teaching point is most appropriate? Pharmacokinetics describes what the body does to a drug.
A. It is unrelated to medication safety or clinical monitoring.
B. It should be ignored unless symptoms persist for several months.
C. It has the opposite physiologic effect in every patient.
D. pharmacokinetics
Answer: D
Integrated Cardiopulmonary Pharmacology — Original Exam Mastery 2026 Page 3
Edition
Original Exam Mastery & Clinical Pharmacology Study Guide • 2026
Scope: 100 independently authored practice questions covering the publicly visible 15-chapter structure of the Fifth Edition, with
emphasis on mechanisms, medication safety, cardiopulmonary application, calculations, and emergency reasoning.
Originality: This resource does not reproduce, reconstruct, or provide the paid Stuvia test bank or publisher test-bank questions.
All questions and explanations here were newly authored for study use.
Source alignment: The referenced Stuvia listing is a paid 1,349-page test-bank resource; its public preview shows Chapter 1 and the related public
Fifth Edition listing identifies chapters on general pharmacology, dosage calculations, autonomic pharmacology, aerosols, bronchodilators,
mucokinetics/surfactants, antiasthmatics, antimicrobials, cardiac agents, blood-pressure/antithrombotic agents,
neuromuscular/sedative/anesthetic/analgesic agents, therapeutic gases, obstructive pulmonary disease, respiratory infections, and emergency
cardiovascular life support. ■cite■turn0view0■turn0search0■
Current evidence note: Drug-development material is aligned with current FDA descriptions of preclinical research, clinical phases, regulatory review,
and post-market monitoring. ■cite■turn1search0■turn1search4■
Integrated Cardiopulmonary Pharmacology — Original Exam Mastery 2026 Page 1
, Study Strategy
• Use active recall: answer before reading the explanation.
• Build every medication around mechanism → indication → onset/duration → adverse effects → monitoring → teaching.
• For respiratory deterioration, assess airway, work of breathing, oxygenation, ventilation, and response.
• For cardiovascular deterioration, prioritize perfusion, rhythm, ischemia, blood pressure, and medication toxicity.
• For calculations, keep units visible and verify unusual results before administration.
Chapter Map
1. General Pharmacology — 6–10 questions
2. Dosage Calculations — 6–10 questions
3. Autonomic Pharmacology — 6–10 questions
4. Aerosol Therapy — 6–10 questions
5. Bronchodilators — 6–10 questions
6. Mucokinetics & Surfactants — 6–10 questions
7. Anti-inflammatory & Antiasthmatic Agents — 6–10 questions
8. Antimicrobial Agents — 6–10 questions
9. Cardiac Agents — 6–10 questions
10. Blood Pressure & Antithrombotic Agents — 6–10 questions
11. Neuromuscular, Sedative, Anesthetic & Analgesic Agents — 6–10 questions
12. Therapeutic Medical Gases — 6–10 questions
13. Obstructive Pulmonary Disease — 6–10 questions
14. Respiratory Infectious Diseases — 6–10 questions
15. Emergency Cardiovascular Life Support — 6–10 questions
Integrated Cardiopulmonary Pharmacology — Original Exam Mastery 2026 Page 2
, Chapter 1: General Pharmacology
1. Which statement is most accurate? Pharmacokinetics describes what the body does to a drug.
A. It is unrelated to medication safety or clinical monitoring.
B. It should be ignored unless symptoms persist for several months.
C. It has the opposite physiologic effect in every patient.
D. pharmacokinetics
Answer: D
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
2. Which finding or action best matches this concept? Pharmacokinetics describes what the body does to a drug.
A. pharmacokinetics
B. It should be ignored unless symptoms persist for several months.
C. It is unrelated to medication safety or clinical monitoring.
D. It has the opposite physiologic effect in every patient.
Answer: A
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
3. Which exam answer best demonstrates understanding of this principle? Pharmacokinetics describes what the body does to
a drug.
A. pharmacokinetics
B. It has the opposite physiologic effect in every patient.
C. It is unrelated to medication safety or clinical monitoring.
D. It should be ignored unless symptoms persist for several months.
Answer: A
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
4. Which option should a clinician recognize as correct? Pharmacokinetics describes what the body does to a drug.
A. It should be ignored unless symptoms persist for several months.
B. It is unrelated to medication safety or clinical monitoring.
C. pharmacokinetics
D. It has the opposite physiologic effect in every patient.
Answer: C
Rationale: Pharmacokinetics describes what the body does to a drug. This matters clinically because correct medication use
depends on matching mechanism and risk to the patient's condition.
5. Which teaching point is most appropriate? Pharmacokinetics describes what the body does to a drug.
A. It is unrelated to medication safety or clinical monitoring.
B. It should be ignored unless symptoms persist for several months.
C. It has the opposite physiologic effect in every patient.
D. pharmacokinetics
Answer: D
Integrated Cardiopulmonary Pharmacology — Original Exam Mastery 2026 Page 3
